Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-09-05 00:00:00 ET · period of report 2024-09-04 · accession 0001968202-24-000126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-05 | 2024-09-04 | REGN | SING GEORGE L | Dir | G - Gift | $0.00 | -1,200 | 26.3K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-04 | G | D | 1,200 | $0.00 | 26,272 | D | — | — |